Latest filing published 18 Sept 2024 for G1 Therapeutics, Inc..
John W. Umstead V appears in our data through filings on G1 Therapeutics, Inc. shares, published by SEC (Form 4). The record holds 11 filings, for trades running from 3 January 2024 to 18 September 2024.
On the market, this insider has only sold: 6 sales, €58k in total. The rest of the record consists of 3 share grants.
On 18 September 2024 came the latest disclosure, a transaction in G1 Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations